New Diagnostic Marker for Lung Cancer Identified

Researchers in Japan recently discovered that patients with lung cancer, including those with Stage 1 disease, have significantly higher-than-normal levels of a biomarker called cytoskeleton-associated protein 4 (CKAP4).
Diane Domina

More Resources